Clinical Trial Update: Neoadjuvant Chemotherapy, Anti-PD-1 Antibody and Sitagliptin for Locally Advanced pMMR CRC [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial is evaluating neoadjuvant chemotherapy combined with an anti-PD-1 antibody and sitagliptin for locally advanced pMMR colorectal…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Anti-PD-1 antibody
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING